Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Buckner
C D
CD
Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Clift
R A
RA
Appelbaum
F R
FR
Storb
R
R
Petersen
F B
FB
Sanders
J E
JE
Thomas
E D
ED
Hansen
J A
JA
D016026:Bone Marrow Transplantation / Q000379:methods*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003524:Cyclosporins / Q000008:administration & dosage; D006086:Graft vs Host Disease / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000601:surgery*; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000601:surgery*; D015993:Life Tables; D008727:Methotrexate / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D016019:Survival Analysis; D014184:Transplantation, Homologous; D014861:Washington / Q000453:epidemiology; D014916:Whole-Body Irradiation
D003524:Cyclosporins; D003520:Cyclophosphamide; D008727:Methotrexate